Aralez to Present at the RBC Capital Markets Global Healthcare Conference

Friday, February 17, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

MISSISSAUGA, Ontario, Feb. 16, 2017 /PRNewswire/ -- Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ), a global specialty

pharmaceutical company, today announced that executive management will participate in the RBC Capital Markets Global Healthcare Conference to be held February 22-23, 2017. Adrian Adams, Chief
Executive Officer, will provide an overview of the Company at 1:35 p.m. local time on Wednesday, February 22, 2017.

A live webcast and audio archive for the event may be accessed from the Investors section of the Aralez website at www.aralez.com. Please connect to the website prior to the start of the presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast.                                                                                                   

About Aralez Pharmaceuticals Inc.

Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ and TSX: ARZ) is a global specialty pharmaceutical company focused on delivering meaningful products to improve patients' lives while creating shareholder value by acquiring, developing and commercializing products primarily in cardiovascular, pain and other specialty areas. Aralez's Global Headquarters is in Mississauga, Ontario, Canada, its U.S. Headquarters is in Princeton, NJ and the Ireland Headquarters is in Dublin, Ireland. More information about Aralez can be found at www.aralez.com.

Contact Information:Aralez Pharmaceuticals US Inc.Nichol OchsnerExecutive Director, Investor Relations & Corporate [email protected]                                               

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/aralez-to-present-at-the-rbc-capital-markets-global-healthcare-conference-300408985.html

SOURCE Aralez Pharmaceuticals Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store